Abogen Biosciences

A discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics.

Launch date

2019

Employees

Market cap

Enterprise valuation

Suzhou Shi Jiangsu (HQ)

Date	Investors	Amount	Round
-	Qiming Venture Partners IMO Ventures MSA Capital Octagon Capital Advisors & 1 more	N/A	-
Jan 2019*	N/A	N/A	Angel
Jul 2020*	N/A	N/A	Seed
Nov 2020	Hillhouse Capital Kanghua Biological SDIC Venture Capital	CNY150m	Series A
Apr 2021	YunFeng Capital TF Capital LYFE Capital Highlight Capital GL Ventures Ming Bioventures SDIC Venture Capital PICC Capital	CNY600m	Series B
Aug 2021	Temasek Boyu Capital Invesco YunFeng Capital Lilly Asia Ventures Loyal Valley Capital GL Ventures 5Y Capital Vision Fund	$700m	Series C
Total Funding		€730m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Abogen Biosciences